Abstract
Experimental chemical carcinogenesis studies in animals are valuable in identifying those biological events or agents that play either an essential or modulatory role in the development of neoplasias. Mouse skin has proved to be one of the best model systems for studying the multistage nature of carcinogenesis (1–3). Skin tumors in mice can be readily induced by the sequential application of a subthreshold dose of a carcinogen (initiation stage) followed by repetititive treatment with a noncarcinogenic tumor promoter (promotion stage). The initiation stage requires only a single application of either a directacting carcinogen or a procarcinogen which requires metabolism before becoming active; it is of an essentially irreversible nature, while the promotion stage is thought to be initially reversible but later becoming irreversible. This second stage, promotion, is most often accomplished by using the phorbol diester 12-0-tetradecanoyl phorbol 13-acetate (TPA), although a variety of agents have been identified as skin tumor promoters, including benzoyl peroxide, anthralin and dihydroteleocidin B (4). In the SENCAR mouse, promotion has been further subdivided into additional stages in which the sequential use of incomplete or partial promoters such as the ionophore A-23187 and mezerein can replace the use of a complete promoter such as TPA (3,5).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Berenblum, I. and Shubik, P. A new, quantitative approach to the study of the stages of chemical carcinogenesis in the mouse skin. Br. J. Cancer 1:373–391, 1947.
Slaga, T.J., Fischer, S.M., Nelson, K., and Gleason, G.L. Studies on the mechanism of skin tumor promotion: Evidence for several stages in promotion, Proc. Natl. Acad. Sci. USA 77 3659–3663, 1980.
Slaga, T.J., Fischer, S.M., Weeks, CE., and Klein-Szanto, A.J.P. In: E. Hodgson, J.R. Bend, R.M. Philpot (eds.), Rev. Biochem. Tox., Elsevier/North Holland, New York, 1981, pp. 231–282.
Slaga, T.J. Mechanisms involved in two-stage carcinogenesis in mouse skin. In: Slaga T.J. (ed.), Mechansims of Tumor Promotion. CRC Press Inc., Boca Raton FL, 1984, pp. 1–16.
Slaga, T.J., Klein-Szanto, A.J.P., Fischer, S.M., Weeks, CE., Nelson, K., and Major, S. Studies on the mechanism of action of anti-tumor promoting agents: Their specificity in two-stage promotion. Proc. Natl. Acad. Sci. USA 77:2251–2254, 1980.
Slaga, T.J., Fischer, S.M., Yiaje, A., Berry, D.L., Bracken, W.M., LeClerc, S., and Miller, D.L. Inhibition of tumor promotion by anti-inflammatory agents: An approach to the biochemical mechanism of promotion. In: T.J. Slaga, A. Sivak and R.K. Boutwell (eds.), Carcinogenesis Vol. 2, Mechanisms of Tumor Promotion and Cocarcinogenesis, Raven Press, New York, 1978, p. 173–195.
Slaga, T.J., Fischer, S.M., Weeks, CE., and Klein-Szanto, A.J.P. Multistage chemical carcinogenesis, In: M. Seije and I.A. Bernstein (eds.), Biochemistry of Normal and Abnormal Epidermal Differentiation, University of Tokyo Press, Tokyo, 1980, pp. 19–218.
Janoff, A., Klassen, A., and Troll, W. Local vascular changes induced by the cocarcinogen phorbol myristate acetate. Cancer Res. 30:2568, 1970.
Marks, F., Berry, D.L., Bertsch, S., Furstenberger, G., and Richter, H. In: E. Hecker, F. Marks, N. Fusenig and T.J. Slaga, (eds.), Cocarcinogenesis and Biological Effects of Tumor Promoters, Raven Press, N.Y., 1982, pp. 331–246.
Schwartz, J.A., Viaje, A., Slaga, T.J., Yuspa, S.H., Hennings, H., and U. Lichti. Fluocinolone acetoni de: A potent inhibitor of mouse skin tumor promotion and epidermal DNA synthesis. Chem. Biol. Interact. 17:331, 1977.
Hong, S.L. and Levine, L. Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids. Proc. Natl. Acad. Sci. 73:1730, 1976.
Gryglewski, R.J. Effects of anti-inflammatory steroids on arachidonate cascade. In: G. Weissman et al. (eds.), Adv. Inflammation Res., Vol. 1, Raven Press; New York, 1979, p. 505.
Belman, S. and Troll, W. The inhibition of croton oil-promoted mouse skin tumori genesi s by steroid hormones. Cancer Res. 32: 450–454, 1972.
Scribner, J.D. and Slaga, T.J. Multiple effects of dexamethasone on protein synthesis and hyperplasia caused by a tumor promoter. Cancer Res. 33:542–546, 1973.
Rohrschneider, L.R. and Boutwell, R.K. The early stimulation of phospholipid metabolism by 12-0-tetradecanoylphorbol-13-acetate and its specificity for tumor promotion. Cancer Res. 33:1945, 1973.
Rohrschneider, L.R., O’Brien, T.H., and Boutwell, R.K. The stimulation of phospholipid metabolism in mouse skin following phorbol ester treatment. Biochim. Biophys. Acta. 280:57, 1972.
Wertz, P.W. and Mueller, G.C. Inhibition of 12-0-tetradecanoyl-phorbol-13-acetate-accelerated phospholipid metabolism by 5,8,11, 14-eicosatetraynoic acid. Cancer Res. 40:776, 1980.
Glavind, J. and Arffmann, E. The possible carcinogenic properties of altered lipids. Acta Path. Microbiol. Scand. Sect. A 78: 345, 1970.
Arffman, E. and Glavind, J. Tumor promoting activity of fatty acid methyl esters in mice. Experientia 27:1765, 1971.
Rohrschneider, L.R. and Boutwell, R.K. Phorbol esters, fatty acids and tumor promotion. Nature (New Biology) 243:212, 1973.
Furstenberger, G. and Marks, F. Tumor promoter 12-0-tetra-decanoylphorbol-13-acetate is not a prostaglandin E-type agonist. Cancer Letters, 6:73–77, 1979.
Brune, K., Kalin, H., Schmidt, R., and Hecker, E. Inflammatory, tumor initiating and promoting activities of polycyclic aromatic hydrocarbons and diterpene esters in mouse skin as compared with their prostaglandin releasing potency in vitro. Cancer Letters, 4:333, 1978.
Bresnick, E., Meunier, P. and Lamden, M. Epidermal prostaglandins after topical application of a tumor promoter. Cancer Letters 7: 121–125, 1979.
Verma, A.K., Ashendel, C.L., Boutwell, R.K. Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins and tumor promotion caused by 12-0-tetradecanoylphorbol-13-acetate. Cancer Res. 40:308–315, 1980.
Boutwell, R.K. Biochemical mechanisms of tumor promotion. In: T.J. Slaga, A. Sivak, and R.K. Boutwell (eds.), Carcinogenesis a Comprehensive Survey, Vol. 2, Raven Press, N.Y., 1978, pp. 49–58.
Verma, A.K., Rice, H.M., and Boutwell, R.K. Prostaglandins and skin tumor promotion: Inhibition of tumor promoter-induced ornithine decarboxylase activity in epidermis by inhibitors of prostaglandin synthesis. Biochem. Biophys. Res. Commun. 79:1160–1166, 1977.
Nakadate, T., Yamamoto, S., Ishii, M., and Kato, R. Inhibition of 12-0-tetradecanoyl-phorbol-13-acetate-induced epidermal ornithine decarboxylase activity by lipoxygenase inhibitors: possible role of product(s) of lipoxygenase pathway. Carcinogenesis 3: 1411–1414, 1982.
Nakadate, T., Yamamoto, S., Ishii, M., and Kato, R. Inhibition of 12-0-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase A2 inhibitors and lipoxygenase inhibitor. Cancer Res. 42:2841–2845, 1982.
Fischer, S.M., Gleason, G.L., Bohrman, J.S., and Slaga, T.J. Prostaglandin modulation of phorbol ester skin tumor promotion. Carcinogenesis 1: 245–248, 1980.
Furstenberger, G. and Marks, F. Studies on the role of prostaglandins in the induction of cell proliferation and hyperplasia and in tumor promotion in mouse skin. In: E. Hecker et al., (eds.), Symp. on Cocarcinogenesis and Biological Effects of Tumor Promoters. Raven Press, N.Y., 1982, pp. 325–330.
Fischer, S.M., Gleason, G.L., Mills, G.D., and Slaga, T.J. Indometacin enhancement of TPA tumor promotion in mice. Cancer Letters 10:343,350, 1980.
Fischer, S.M. The role of prostaglandins in tumor promotion. In: T.J. Slaga (ed.), Mechanisms of Tumor Promotion, Vol. II Tumor Promotion and Skin Carcinogenesis, CRC Press, Inc., Boca Raton, 1983, pp. 113–126.
Fischer, S.M., Mills, G.D., and Slaga, T.J. Inhibition of mouse skin tumor promotion by several inhibitors of arachidonic acid metabolism. Carcinogenesis 3:1243–1245, 1982.
Nakadate, T., Yamamoto, S., Iseki, H., Sonoda, S., Takemura, S., Ura, A., Hosoda, Y., and Kato, R. Inhibition of 12-0-tetradecanoylphorbol-13-acetate-induced tumor promotion by nordihydroguaiaretic acid, a lipoxygenase inhibitor and p-bromophenacyl bromide, a phospholipase A2 inhibitor. Gann 73:841–843, 1982.
Kato, R., Nakadate, T., Yamamoto, S., and Sugimura, T. Inhibition of 12-0-tetradecanoylphorbol-13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: possible involvement of lipoxygenase inhibition. Carcinogenesis 4:13011305, 1983.
Hamberg, M. and Samuelsson, B. Prostaglandin endoperoxides. Novel transformations of arachidonlc acid in human platlets. Proc. Natl. Acad. Sci. 71:3400, 1974.
Hammarstrom, S., Hamberg, M., Samuelsson, B., Duell, E., Stawiski, M., and Vorhees, J.J. Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy 5,8,10,14-eicosatetraenoic acid, prostaglandin E2 and prostaglandin F2α in epidermis of psoriasis, Proc. Natl. Acad. Sci. USA, 72:5130, 1975.
Hamberg, M. and Samuelsson, B. Prostaglandins in human seminal plasma. J. Biol. Chem. 241:257, 1966.
Fischer, S.M. and Slaga, T.J. Modulation of prostaglandin synthesis and tumor promotion. In: T.J. Poweles et al. (eds.), Prostaglandins and Cancer First International Conference, Alan R. Liss, Inc., New York, 1982, pp. 255–264.
Colburn, N.H., Vorder Bruegge, W.F., Bates, J.R., Gray, R.H., Rossen, J.D., Kelsey, W.H., and Shlmada, T. Correlation of anchorage independent growth with tumorigenicity of chemically transformed mouse epidermal cells. Cancer Res. 38:624–634, 1978.
Slaga, T.J., Yiaje, A., Bracken, W.M., Buty, S.G., Miller, D.R., Fischer, S.M., Richter, CK., and Dumont, J.N. In vitro transformation of epidermal cells from newborn mice. Cancer Res. 38:2246–2252, 1978.
Fischer, S.M., Yiaje, A., Harris, K.L., Miller, D.R., Bohrman, J.S. and Slaga, T.J. Improved conditions for murine epidermal cell culture. In Vitro 16: 180–188, 1980.
Yotti, L.P., Chang, C.C., and Trosko, J.E. Elimination of metacooperatlon in Chinese hamster cells by a tumor promoter. Science 206, 1989–1091, 1979.
Murray, A.W. and Fitzgerald, D.J. Tumor promoters inhibit metabolic cooperation In cocultures of epidermal and 3T3 cells. Biochem. Blophys. Res. Commun. 91:395, 1979.
Slaga, T.J., Klein-Szanto, A.J.P., Triplett, L.L. and Yotti, L.P. Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound. Science 213:1023–1025, 1981.
Fischer, S.M., Mills, G.D., and Slaga, T.J. In: B. Sammuelsson, R. Paoletti, and P. Ramwell (eds.), Adv. Prostaglandin, Thromboxane and Leukotriene Research, Vol. 12, Raven Press, New York, 1983, pp. 309–312.
Kensler, T.W., Bush, D.M. and Kozumbo, W.J. Inhibition of tumor promotion by a biomimetic superoxide dismutase. Science 221: 75–77, 1983.
Kensler, T.W. and Trush, M.A. Inhibition of oxygen radical metabolism in phorbol ester-activated poly morphonuclear leukocytes by an antitumor promoting copper complex with superoxide dismutase mimetic activity. Biochem. Pharmacol. 32:3485–3487, 1983.
Goldstein, B.D., Witz, G., Amoruso M., and Troll, W. Protease inhibitors antagonize the activation of polymorphonuclear leukocyte oxygen consumption. Biochem. Biophys. Res. Commun. 88:854–860, 1979.
Goldstein, B.D., Witz, G., Amoruso, M., Stone, D.S., and Troll, W. Stimulation of human polymorphonuclear leukocytes superoxide anion radical production by tumor promoters. Cancer Letters 11:154, 1981.
Kensler, T.W. and Trush, M.A. Inhibition of phorbol esterstimulated chemiluminescence in human polymorphonuclear leukocytes by retinoic acid and 5,6 epoxyretinoic acid. Cancer Res. 41:216–222, 1981.
Fischer, S.M. and Adams, L.A. Tumor promoter-induced chemiluminescence in mouse epidermal cells is inhibited by several inhibitors of arachidonic acid metabolism, (submitted)
Trush, M.A., Wilson, M.E., and Van Dyke, K. The generation of chemiluminescence by phagocytic cells. Methods Enzymol. 57:462–494, 1978.
DeChatelet, L.R., McCall, CE., McPhail, L.C. and Johnston, R.B. Superoxide dismutase activity in leukocytes. J. Chm. Invest. 53: 1197–1201, 1974.
Solanki, V., Rana, R.S., and Slaga, T.J. Diminuition of mouse superoxide dismutase and catalase activities by tumor promoters. Carcinogenesis 2: 1141–1146, 1981.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Fischer, S.M. (1985). Arachidonic Acid Metabolism and Tumor Promotion. In: Fischer, S.M., Slaga, T.J. (eds) Arachidonic Acid Metabolism and Tumor Promotion. Prostaglandins, Leukotrienes, and Cancer, vol 3. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2605-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2605-2_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9631-7
Online ISBN: 978-1-4613-2605-2
eBook Packages: Springer Book Archive